Opiant Pharmaceuticals, Inc. (OPNT)
USD 20.65
(0.0%)
USD 20.65
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 40.72 Million | 27.4 Million | 38.23 Million | 13.51 Million | 18.44 Million | 9.89 Million |
| Cost of Revenue | 9.06 Million | 6.19 Million | 7.72 Million | 1.49 Million | - | - |
| Gross Profit | 31.65 Million | 21.2 Million | 30.51 Million | 12.02 Million | 18.44 Million | 9.89 Million |
| Operating Expenses | 26.5 Million | 23.44 Million | 19.6 Million | 33.21 Million | 11.35 Million | 17.63 Million |
| Selling, General and Administrative Expenses | 16.72 Million | 16.42 Million | 12.8 Million | 11.47 Million | 8.18 Million | 15.88 Million |
| Research and Development Expenses | 16.83 Million | 9.24 Million | 9.07 Million | 8.47 Million | 3.17 Million | 1.74 Million |
| Other Expenses | -7.06 Million | -2.22 Million | -2.28 Million | 13.25 Million | - | - |
| Cost and Expenses | 35.56 Million | 29.64 Million | 27.32 Million | 34.7 Million | 11.35 Million | 17.63 Million |
| Operating Income | 5.15 Million | -2.24 Million | 10.91 Million | -21.19 Million | 7.09 Million | -7.73 Million |
| Interest Expense | 2.12 Million | 131 Thousand | - | - | 3716.00 | 11.89 Thousand |
| Income Tax Expense | 24.27 Thousand | -425.67 Thousand | -177.23 Thousand | 51.28 Thousand | 550.47 Thousand | -51.99 Thousand |
| Earnings before Tax | 3.03 Million | -2.28 Million | 11.41 Million | -21.14 Million | 7.13 Million | -7.81 Million |
| Net Income | 3 Million | -1.86 Million | 11.59 Million | -21.19 Million | 6.58 Million | -7.81 Million |
| Earnings Per Share Basic | 0.68 | -0.44 | 2.88 | -7.10 | 3.27 | -4.09 |
| Earnings Per Share Diluted | 0.51 | -0.44 | 2.17 | -7.10 | 2.94 | -4.09 |
| Weighted Average Shares Outstanding | 4.45 Million | 4.24 Million | 4.01 Million | 2.98 Million | 2.01 Million | 1.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.92 Million | 4.24 Million | 5.34 Million | 2.98 Million | 2.23 Million | 1.91 Million |
| Gross Margin | 0.78 | 0.77 | 0.80 | 0.89 | 1.00 | 1.00 |
| EBIT Margin | 0.14 | -0.06 | 0.29 | -1.56 | 0.39 | -0.79 |
| Profit Margin | 0.07 | -0.07 | 0.30 | -1.57 | 0.36 | -0.79 |
| EBITDA | 5.82 Million | -1.53 Million | 11.08 Million | -21.14 Million | 7.13 Million | -7.79 Million |
| Earnings Before Tax Margin | 0.13 | -0.08 | 0.29 | -1.57 | 0.38 | -0.78 |
| Breakdown | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 FY | 2021 Q4 | 2021 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 173.87 Million | 2.32 Million | 2.19 Million | 40.72 Million | 13.03 Million | 14.04 Million |
| Cost of Revenue | - | 517.01 Thousand | 426.25 Thousand | 9.06 Million | 2.92 Million | 3.05 Million |
| Gross Profit | 173.87 Million | 1.8 Million | 1.76 Million | 31.65 Million | 10.11 Million | 10.98 Million |
| Operating Expenses | 9.62 Million | 13.17 Million | 13.55 Million | 26.5 Million | 8.84 Million | 7.02 Million |
| Selling, General and Administrative Expenses | 5.66 Million | 6.82 Million | 7 Million | - | 4.89 Million | 4.43 Million |
| Research and Development Expenses | 4.13 Million | 7.91 Million | 8.82 Million | - | 4.71 Million | 4.88 Million |
| Other Expenses | -173.87 Thousand | -1.56 Million | -2.27 Million | -7.06 Million | 9.07 Billion | 3.05 Billion |
| Cost and Expenses | 9.62 Million | 13.69 Million | 13.98 Million | 35.56 Million | 11.76 Million | 10.08 Million |
| Operating Income | -9.62 Million | -11.36 Million | -11.78 Million | 5.15 Million | 1.27 Million | 3.96 Million |
| Interest Expense | 390.85 Thousand | 401.28 Thousand | 420.89 Thousand | 2.12 Million | 502.68 Thousand | 547.29 Thousand |
| Income Tax Expense | 8550.00 | 32.48 Thousand | 399.86 Thousand | 24.27 Thousand | 24.27 Thousand | 547.75 Thousand |
| Earnings before Tax | -9.9 Million | -11.7 Million | -12.18 Million | 3.03 Million | 776.6 Thousand | 3.41 Million |
| Net Income | -9.91 Million | -11.73 Million | -12.58 Million | 3 Million | 752.33 Thousand | 3.41 Million |
| Earnings Per Share Basic | -1.93 | -2.31 | -2.51 | - | 0.17 | 0.77 |
| Earnings Per Share Diluted | -1.93 | -2.31 | -2.51 | - | 0.13 | 0.56 |
| Weighted Average Shares Outstanding | 5.13 Million | 5.08 Million | 5.01 Million | 4.45 Million | 4.45 Million | 4.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.13 Million | 5.08 Million | 5.01 Million | 5.92 Million | 5.92 Million | 6.06 Million |
| Gross Margin | 1.00 | 0.78 | 0.81 | 0.78 | 0.78 | 0.78 |
| EBIT Margin | -0.05 | -4.86 | -5.37 | - | 0.14 | 0.28 |
| Profit Margin | -0.06 | -5.05 | -5.74 | 0.07 | 0.06 | 0.24 |
| EBITDA | -9.45 Million | -11.29 Million | -11.77 Million | - | 1.86 Million | 3.98 Million |
| Earnings Before Tax Margin | -0.06 | -4.89 | -5.37 | 0.13 | 0.10 | 0.28 |
MRT
ACHKF
ADK
603223
4385
OPINL